As of November 6, 2026, Dolby Laboratories, Inc. is a publicly traded company (NYSE: DLB). The largest holder reporting an active stake on Schedule 13D is Dagmar Dolby, at 36%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include BlackRock (10%), Bank of New York Mellon Corp (8.6%), Vanguard (8.24%) (Schedule 13D/A, February 13, 2026).
Is this your company?
About to sign with, pay or invest in Dolby Laboratories, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Dolby Laboratories, Inc. a real, registered company?
- Dolby Laboratories, Inc. files with the SEC under CIK 1308547 (its SEC filings).
- Its shares are listed under the ticker DLB on NYSE (SEC company record).
- Incorporated in Delaware; business address in San Francisco, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Dolby Laboratories, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Marc Whitten, President and Chief Executive Officer (Form 8-K filed 2026-08-27). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names First Trust Portfolios L.P. (filed 2026-10-27).
Who are Dolby Laboratories, Inc.'s owners and officers?
Dolby Laboratories, Inc.: incorporated in Delaware; business address in San Francisco, California; industry Patent Owners & Lessors (Schedule 13G, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-27 | First Trust Portfolios L.P. | 5.09% |
| Schedule 13G/A, 2026-10-22 | Bank Of New York Mellon Corp | 8.6% |
| Schedule 13G/A, 2026-06-04 | Blackrock, Inc. | 10% |
| Schedule 13G/A, 2026-05-11 | Morgan Stanley | 8.2% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 5.24% |
| Schedule 13G, 2026-04-29 | Vanguard Portfolio Management | 8.24% |
| Schedule 13G/A, 2026-04-28 | Bank Of New York Mellon Corp | 7.4% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13D/A, 2026-02-13 | Dagmar Dolby | 36% |
| Schedule 13G/A, 2026-02-11 | Morgan Stanley | 10.2% |
Questions about who owns Dolby Laboratories, Inc.
Who owns Dolby Laboratories, Inc.?
On this page, 7 holders' latest ownership filings report 5% or more of Dolby Laboratories, Inc.: Dagmar Dolby (36%, Schedule 13D/A, filed 2026-02-13), Blackrock, Inc. (10%, Schedule 13G/A, filed 2026-06-04), Bank Of New York Mellon Corp (8.6%, Schedule 13G/A, filed 2026-10-22), Vanguard Portfolio Management (8.24%, Schedule 13G, filed 2026-04-29) and Morgan Stanley (8.2%, Schedule 13G/A, filed 2026-05-11); 2 more are listed above.
Who are the largest shareholders of Dolby Laboratories, Inc.?
By the share each holder's latest filing reports, the largest holders of Dolby Laboratories, Inc. on this page are Dagmar Dolby (36%), Blackrock, Inc. (10%) and Bank Of New York Mellon Corp (8.6%).
When did Dagmar Dolby buy into Dolby Laboratories, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Dagmar Dolby on this page is the Schedule 13D/A, filed 2026-02-13, reporting 36%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Dolby Laboratories, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Dolby Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dolby Laboratories, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-27 | Marc Whitten | President and Chief Executive Officer | appointed | 2026-08-27 |
Which insiders own Dolby Laboratories, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 242,163.56 shares, 143,784 held directly and 98,379.56 indirectly (Form 4, 2025-12-17).
- , the senior vice president and entertainment: 166,803 shares (Form 4, 2026-10-05).
- , the chief executive and president: 160,256 shares (Form 4, 2026-09-17).
- , the executive vice president and general counsel: 119,024 shares (Form 4, 2026-09-17).
- , a director and 10% owner: 92,718 shares (Form 4, 2026-02-05).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has Dolby Laboratories, Inc. raised?
No fundraising or offering filing from Dolby Laboratories, Inc. is on file with us.
Keep reading
More on Dolby Laboratories, Inc. and the records around it.
Dolby Laboratories, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Aug 2026
Companies that share a holder
- Bank of New York Mellon Corp also filed stake reports on 26 other companies: FIRST HORIZON CORP (Oct 2026), First Watch Restaurant Group, Inc. (Oct 2026), Hess Midstream LP (Oct 2026)
- First Trust Portfolios L.P. also filed stake reports on 105 other companies: First Trust Exchange-Traded Fund (Nov 2026), First Trust Exchange-Traded Fund IV (Nov 2026), First Trust Exchange-Traded Fund VIII (Nov 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/dolby-laboratories